Eph and ephrins in epithelial stem cell niches and cancer

Cell Adhesion and Migration

Volumn 6, Issue 2, 2012, Pages 126-130

  Genander, Maria ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN; EPHRIN A1; EPHRIN A4; EPHRIN A5; EPHRIN B1; EPHRIN B2; EPHRIN B3; EPHRIN RECEPTOR; EPHRIN RECEPTOR A2; EPHRIN RECEPTOR A7; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B3; EPHRIN RECEPTOR B4; PHOSPHATIDYLINOSITOL 3 KINASE; WNT PROTEIN;

CARCINOGENESIS; CELL PROLIFERATION; CRYPT CELL; EPITHELIAL STEM CELL; INTESTINE EPITHELIUM; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL NICHE;

EID: 84863927106     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.18932     Document Type: Review

References (48)

1. Hirai H, Maru Y, Hagiwara K, Nishida J, Takaku F. A novel putative tyrosine kinase receptor encoded by the eph gene. Science 1987; 238:1717-20; PMID: 2825356; http://dx.doi.org/10.1126/science.2825356
2. Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, et al. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 1994; 266:816-9; PMID:7973638; http://dx.doi.org/10.1126/science. 7973638
3. Beckmann MP, Cerretti DP, Baum P, Vanden Bos T, James L, Farrah T, et al. Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors. EMBO J 1994; 13:3757-62; PMID: 8070404
4. Lackmann M, Boyd AW. Eph, a protein family coming of age: more confusion, insight, or complexity? Sci Signal 2008; 1:re2; PMID:18413883; http://dx.doi.org/10.1126/stke.115re2
5. Holmberg J, Clarke DL, Frisen J. Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature 2000; 408:203-6; PMID: 11089974; http://dx.doi.org/10.1038/35041577
6. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008; 133:38-52; PMID: 18394988; http://dx.doi.org/10.1016/j.cell. 2008.03.011
7. Himanen JP, Saha N, Nikolov DB. Cell-cell signaling via Eph receptors and ephrins. Curr Opin Cell Biol 2007; 19:534-42; PMID:17928214; http://dx.doi.org/10.1016/j.ceb.2007.08.004
8. Himanen JP, Chumley MJ, Lackmann M, Li C, Barton WA, Jeffrey PD, et al. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci 2004; 7:501-9; PMID: 15107857; http://dx.doi.org/10. 1038/nn1237
9. Lackmann M, Mann RJ, Kravets L, Smith FM, Bucci TA, Maxwell KF, et al. Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptor. J Biol Chem 1997; 272:16521-30; PMID:9195962; http://dx.doi.org/10.1074/jbc.272.26.16521
10. Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, Ryan TE, et al. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 1996; 17:9-19; PMID:8755474; http://dx.doi.org/10.1016/S0896-6273(00)80276-7
11. Gale NW, Flenniken A, Compton DC, Jenkins N, Copeland NG, Gilbert DJ, et al. Elk-L3, a novel transmembrane ligand for the Eph family of receptor tyrosine kinases, expressed in embryonic floor plate, roof plate and hindbrain segments. Oncogene 1996; 13:1343-52; PMID:8808709
12. Wybenga-Groot LE, Baskin B, Ong SH, Tong J, Pawson T, Sicheri F. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 2001; 106: 745-57; PMID:11572780; http://dx.doi.org/10.1016/S0092-8674(01)00496-2
13. Brückner K, Pasquale EB, Klein R. Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science 1997; 275:1640-3; PMID:9054357; http://dx.doi.org/10.1126/science.275.5306.1640
14. Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M, Pawson T. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 1996; 383:722-5; PMID: 8878483; http://dx.doi.org/10.1038/383722a0
15. Kalo MS, Yu HH, Pasquale EB. In vivo tyrosine phosphorylation sites of activated ephrin-B1 and ephB2 from neural tissue. J Biol Chem 2001; 276: 38940-8; PMID:11466320; http://dx.doi.org/10.1074/jbc.M105815200
16. Lim YS, McLaughlin T, Sung TC, Santiago A, Lee KF, O'Leary DD. p75(NTR) mediates ephrin-A reverse signaling required for axon repulsion and mapping. Neuron 2008; 59:746-58; PMID:18786358; http://dx.doi.org/10.1016/j.neuron.2008. 07.032
17. Holmberg J, Genander M, Halford MM, Anneren C, Sondell M, Chumley MJ, et al. EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell 2006; 125:1151-63; PMID: 16777604; http://dx.doi.org/10.1016/ j.cell.2006.04.030
18. Holmberg J, Armulik A, Senti KA, Edoff K, Spalding K, Momma S, et al. Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis. Genes Dev 2005; 19:462-71; PMID: 15713841; http://dx.doi.org/10.1101/gad.326905
19. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002; 111:251-63; PMID:12408869; http://dx.doi.org/10.1016/S0092-8674(02)01015-2
20. Clevers H, Batlle E. EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer Res 2006; 66:2-5; PMID:16397205; http://dx.doi.org/10. 1158/0008-5472.CAN-05-3849
21. Cortina C, Palomo-Ponce S, Iglesias M, Fernandez-Masip JL, Vivancos A, Whissell G, et al. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet 2007;39:1376-83; PMID:17906625; http://dx.doi.org/10.1038/ng.2007.11
22. Batlle E, Bacani J, Begthel H, Jonkheer S, Gregorieff A, van de Born M, et al. EphB receptor activity suppresses colorectal cancer progression. Nature 2005; 435:1126-30; PMID:15973414; http://dx.doi.org/10.1038/nature03626
23. Davalos V, Dopeso H, Castano J, Wilson AJ, Vilardell F, Romero-Gimenez J, et al. EPHB4 and survival of colorectal cancer patients. Cancer Res 2006; 66:8943-8; PMID:16982731; http://dx.doi.org/10.1158/0008-5472.CAN-05-4640
24. Guo DL, Zhang J, Yuen ST, Tsui WY, Chan AS, Ho C, et al. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. Carcinogenesis 2006; 27:454-64; PMID:16272170; http://dx.doi.org/10. 1093/carcin/bgi259
25. Munarini N, Jager R, Abderhalden S, Zuercher G, Rohrbach V, Loercher S, et al. Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. J Cell Sci 2002; 115:25-37; PMID:11801721
26. Nikolova Z, Djonov V, Zuercher G, Andres AC, Ziemiecki A. Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. J Cell Sci 1998; 111:2741-51; PMID:9718367
27. Wu Q, Suo Z, Risberg B, Karlsson MG, Villman K, Nesland JM. Expression of Ephb2 and Ephb4 in breast carcinoma. Pathol Oncol Res 2004; 10:26-33; PMID: 15029258; http://dx.doi.org/10.1007/BF02893405
28. Berclaz G, Flutsch B, Altermatt HJ, Rohrbach V, Djonov V, Ziemiecki A, et al. Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast. Oncol Rep 2002; 9:985-9; PMID:12168060
29. Vaught D, Chen J, Brantley-Sieders DM. Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinase. Mol Biol Cell 2009; 20:2572-81; PMID:19321667; http://dx.doi.org/10.1091/mbc.E08-04-0378
30. Noren NK, Foos G, Hauser CA, Pasquale EB. The EphB4 receptor suppresses breast cancer cell tumor-igenicity through an Abl-Crk pathway. Nat Cell Biol 2006; 8:815-25; PMID:16862147; http://dx.doi.org/10.1038/ncb1438
31. Zelinski DP, Zantek ND, Stewart JC, Irizarry AR, Kinch MS. EphA2 overexpression causes tumor-igenesis of mammary epithelial cells. Cancer Res 2001; 61: 2301-6; PMID:11280802
32. Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, et al. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumor-igenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Invest 2008; 118:64-78; PMID:18079969; http://dx.doi.org/10.1172/ JCI33154
33. Fournier MV, Martin KJ, Kenny PA, Xhaja K, Bosch I, Yaswen P, et al. Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. Cancer Res 2006; 66: 7095-102; PMID:16849555; http://dx.doi.org/10.1158/0008-5472.CAN-06-0515
34. Martin KJ, Patrick DR, Bissell MJ, Fournier MV. Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS ONE 2008; 3: e2994; PMID:18714348; http://dx.doi.org/10.1371/journal.pone.0002994
35. Tumbar T, Guasch G, Greco V, Blanpain C, LowryWE, Rendl M, et al. Defining the epithelial stem cell niche in skin. Science 2004; 303:359-63; PMID:14671312; http://dx.doi.org/10.1126/science.1092436
36. Guo H, Miao H, Gerber L, Singh J, Denning MF, Gilliam AC, et al. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin. Cancer Res 2006; 66: 7050-8; PMID:16849550; http://dx.doi.org/10.1158/0008-5472.CAN-06-0004
37. Genander M, Holmberg J, Frisen J. Ephrins negatively regulate cell proliferation in the epidermis and hair follicle. Stem Cells 2010; 28:1196-205; PMID: 20506314
38. Egawa G, Osawa M, Uemura A, Miyachi Y, Nishikawa SI. Transient expression of ephrin b2 in perinatal skin is required for maintenance of keratinocyte homeostasis. J Invest Dermatol 2009; 129:2386-95; PMID:19571816; http://dx.doi.org/10.1038/jid.2009.105
39. Hafner C, Becker B, Landthaler M, Vogt T. Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol 2006; 19: 1369-77; PMID:16862074; http://dx.doi.org/10.1038/modpathol.3800660
40. Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, et al. EphB4 expression and biological significance in prostate cancer. Cancer Res 2005; 65:4623-32; PMID:15930280; http://dx.doi.org/10.1158/0008-5472.CAN-04-2667
41. Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, et al. Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate 1999; 41:275-80;PMID:10544301; http://dx.doi.org/10.1002/ (SICI)1097- 0045(19991201)41:4〈275::AID-PROS8〉3.0.CO;2-T
42. Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, Tuzmen S, et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat Genet 2004; 36:979-83; PMID:15300251; http://dx.doi.org/10.1038/ng1408
43. Guan M, Xu C, Zhang F, Ye C. Aberrant methylation of EphA7 in human prostate cancer and its relation to clinicopathologic features. Int J Cancer 2009; 124:88-94; PMID:18821581; http://dx.doi.org/10.1002/ijc.23890
44. Andres AC, Ziemiecki A. Eph and ephrin signaling in mammary gland morphogenesis and cancer. J Mammary Gland Biol Neoplasia 2003; 8:475-85; PMID:14985642; http://dx.doi.org/10.1023/B:JOMG.0000017433.83226.22
45. Miao H, Strebhardt K, Pasquale EB, Shen TL, Guan JL, Wang B. Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases. J Biol Chem 2005; 280:923-32; PMID:15536074; http://dx.doi.org/10.1074/ jbc.M411383200
46. Taddei ML, Parri M, Angelucci A, Onnis B, Bianchini F, Giannoni E, et al. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Am J Pathol 2009; 174: 1492-503; PMID:19264906; http://dx.doi.org/10.2353/ajpath.2009.080473
47. Gu C, Park S. The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. Mol Cell Biol 2001; 21:4579-97; PMID:11416136; http://dx.doi.org/10.1128/MCB.21.14.4579-4597.2001
48. Genander M, Halford MM, Xu NJ, Eriksson M, Yu Z, Qiu Z, et al. Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. Cell 2009; 139:679-92; PMID:19914164; http://dx.doi.org/10.1016/j.cell.2009.08.048